通过专为投资者打造的一站式数据看板，全面查看 Grace Therapeutics, Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图，助您更轻松地进行财务分析。您可以查看最新年度财务报告，也可以通过利润表、资产负债表和现金流量表，按季度分析公司表现。借助实时财务指标，持续追踪公司的经营状况和市场表现更加便捷。

关键财务比率

总市值

33.19M

股息TTM

0.00

市盈率 TTM

-6.55

每股收益TTM

-0.31

营业收入

净利润

-9.57M

净资产收益率

-10.22%

总资产收益率

-9.22%

Grace Therapeutics, Inc 财报日历

财务报表摘要

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2027Q1

FY2026Q4

FY2026Q3

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

财务指标

每股收益

-333.07%-0.91

-248.45%-0.07

62.14%-0.14

80.25%-0.06

11.83%-0.21

113.65%0.05

-73.78%-0.36

31.17%-0.30

55.74%-0.24

91.32%-0.34

60.27%-0.21

---0.43

---0.54

---3.88

---0.52

----

营业收入

----

--0.00

-100.00%0.00

----

净利润

-369.66%-15.79M

-285.22%-1.18M

44.28%-2.31M

72.67%-938.00K

-28.47%-3.36M

120.09%636.00K

-73.78%-4.16M

-4.86%-3.43M

34.95%-2.62M

89.12%-3.17M

38.52%-2.39M

33.60%-3.27M

11.07%-4.02M

-645.06%-29.09M

-2.94%-3.89M

-602.45%-4.93M

-45.09%-4.52M

---3.90M

-17.33%-3.78M

115.96%981.00K

利润表

营业收入

----

--0.00

-100.00%0.00

----

营业利润

22.85%-2.38M

5.44%-3.01M

33.88%-2.45M

47.65%-2.53M

37.74%-3.09M

2.45%-3.18M

-21.72%-3.70M

-133.04%-4.83M

-67.90%-4.96M

21.66%-3.26M

28.32%-3.04M

59.41%-2.07M

37.51%-2.96M

5.41%-4.17M

-0.47%-4.25M

-43.17%-5.11M

-50.40%-4.73M

---4.40M

-115.12%-4.22M

-29.99%-3.57M

净利润

-369.66%-15.79M

-285.22%-1.18M

44.28%-2.31M

72.67%-938.00K

-28.47%-3.36M

120.09%636.00K

-73.78%-4.16M

-4.86%-3.43M

34.95%-2.62M

89.12%-3.17M

38.52%-2.39M

33.60%-3.27M

11.07%-4.02M

-645.06%-29.09M

-2.94%-3.89M

-602.45%-4.93M

-45.09%-4.52M

---3.90M

-17.33%-3.78M

115.96%981.00K

资产负债表

流动资产

-30.17%14.33M

-23.48%17.38M

60.91%19.21M

7.70%17.30M

0.47%20.52M

-5.41%22.71M

-55.59%11.94M

-44.40%16.06M

-13.48%20.43M

-18.03%24.01M

-19.58%26.88M

-22.98%28.89M

-42.76%23.61M

-35.32%29.29M

-31.78%33.43M

-31.24%37.51M

-31.69%41.25M

--45.28M

62.25%49.00M

297.76%54.55M

流动负债总额

-46.00%1.25M

11.19%2.15M

-34.86%1.28M

-53.44%1.25M

-10.96%2.31M

14.61%1.93M

11.36%1.97M

91.41%2.67M

32.25%2.60M

-50.63%1.68M

-48.44%1.77M

-63.29%1.40M

-46.97%1.97M

4.63%3.41M

18.50%3.43M

-14.99%3.81M

58.08%3.71M

--3.26M

28.87%2.90M

19.33%4.48M

总资产

-28.27%50.07M

-7.42%66.65M

11.86%68.49M

1.88%66.58M

0.12%69.81M

-1.78%71.99M

-19.64%61.22M

-16.44%65.35M

-4.54%69.72M

-7.36%73.30M

-34.77%76.19M

-35.32%78.21M

-41.54%73.03M

-38.48%79.12M

2.25%116.80M

0.93%120.91M

106.66%124.93M

--128.62M

276.95%114.23M

766.08%119.80M

总负债

-70.23%1.86M

-48.76%2.76M

-60.42%3.60M

-59.22%3.76M

-39.59%6.25M

-53.42%5.38M

-21.03%9.09M

-19.62%9.21M

14.75%10.35M

3.48%11.56M

-42.71%11.51M

-44.74%11.46M

-56.05%9.02M

-45.12%11.17M

534.47%20.08M

271.01%20.75M

193.42%20.53M

--20.35M

-31.02%3.17M

12.76%5.59M

总权益

-24.14%48.21M

-4.07%63.90M

24.46%64.89M

11.91%62.82M

7.05%63.55M

7.88%66.61M

-19.39%52.14M

-15.90%56.13M

-7.26%59.36M

-9.14%61.74M

-33.13%64.68M

-33.36%66.75M

-38.69%64.01M

-37.24%67.95M

-12.91%96.72M

-12.29%100.16M

95.30%104.40M

--108.27M

331.90%111.06M

1187.10%114.20M

现金流量表

经营净额

-78.85%-3.22M

42.62%-1.70M

45.81%-2.23M

25.86%-3.14M

49.92%-1.80M

-41.48%-2.95M

-117.49%-4.12M

-100.62%-4.24M

42.37%-3.60M

37.22%-2.09M

49.17%-1.89M

38.56%-2.11M

-15.00%-6.24M

-5.76%-3.33M

18.80%-3.72M

43.66%-3.44M

-59.54%-5.43M

---3.15M

-8.78%-4.58M

-46.10%-6.10M

投资净额

----

--0.00

-100.00%0.00

--0.00

100.00%0.00

-100.00%0.00

100.23%15.00K

-100.00%0.00

---15.00K

31.17%6.55M

-31.05%-6.55M

214.58%110.00K

-100.00%0.00

45281.82%4.99M

-997.85%-5.00M

-103.38%-96.00K

291.40%13.26M

--11.00K

140.60%557.00K

8696.97%2.84M

融资净额

100.00%0.00

-100.00%0.00

--4.04M

--0.00

---327.00K

--14.03M

--0.00

----

--0.00

6651.38%7.36M

-100.00%0.00

--0.00

--109.00K

--195.00K

--0.00

-100.00%0.00

营业收入

业务

报告期:

暂无数据

地区

报告期:

暂无数据

常见问题

Grace Therapeutics, Inc的流动资产是多少？



根据Grace Therapeutics, Inc的FY2026财报，流动资产为17.38M（同比变化-23.48）。

Grace Therapeutics, Inc的总资产是多少？



根据Grace Therapeutics, Inc的FY2026财报，Grace Therapeutics, Inc的总资产为66.65M（同比变化-7.42）。

Grace Therapeutics, Inc的总负债是多少？



根据Grace Therapeutics, Inc的FY2026财报，Grace Therapeutics, Inc的总负债为2.76M（同比变化-48.76）。

Grace Therapeutics, Inc的总权益是多少？



根据Grace Therapeutics, Inc的FY2026财报，Grace Therapeutics, Inc的总权益为63.90M（同比变化-4.07）。

Grace Therapeutics, Inc的净营业收入是多少？



根据Grace Therapeutics, Inc的FY2026财报，Grace Therapeutics, Inc的净营业收入为-11.08M（同比变化33.59）。

Grace Therapeutics, Inc的净融资是多少？



根据Grace Therapeutics, Inc的FY2026财报，Grace Therapeutics, Inc的净融资为3.71M（同比变化-73.54）。

Grace Therapeutics, Inc的每股收益（EPS）是多少？



根据Grace Therapeutics, Inc的FY2026财报，每股收益（EPS）为-0.47（同比变化40.37）。

Grace Therapeutics, Inc的净利润是多少？



根据Grace Therapeutics, Inc的FY2026财报，净利润为-7.79M（同比变化18.55）。

Grace Therapeutics, Inc的股东权益回报率（ROE）是多少？



根据Grace Therapeutics, Inc的FY2026财报，股东权益回报率（ROE）为-11.94（同比变化19.90）。

Grace Therapeutics, Inc的资产回报率（ROA）是多少？



根据Grace Therapeutics, Inc的FY2026财报，资产回报率（ROA）为-11.24（同比变化14.65）。

Grace Therapeutics, Inc的营业利润是多少？



根据Grace Therapeutics, Inc的FY2026财报，营业利润为-11.08M（同比变化33.59）。